Artwork

Sisällön tarjoaa peopleofpathology. peopleofpathology tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Episode 183: Joseph Mossel - Revolutionizing Pathology with AI: A Conversation with IBEX Co-Founder

30:15
 
Jaa
 

Manage episode 422792301 series 3385006
Sisällön tarjoaa peopleofpathology. peopleofpathology tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Jospeh Mossel co-founded Ibex in 2016. Since its inception, Ibex has remained committed to developing AI applications for clinical diagnostics.

The company achieved its first milestone in 2018 by deploying its first algorithm for prostate cancer. This algorithm not only enhanced diagnostic efficiency but also detected a diagnostic error, demonstrating the value of AI in pathology.

Over the years, IBEX has expanded its offerings to include algorithms for breast and gastric cancers, facing challenges due to the unique characteristics of each tissue type. However, through partnerships with healthcare organizations and pharmaceutical companies, IBEX has continued to innovate and grow.

This conversation covers the history of Ibex and some of their milestones. We conclude with a look toward the future of AI in pathology.

Links for this episode:

Health Podcast Network

LabVine Learning

Dress A Med scrubs

Digital Pathology Club

Ibex Medical Analytics

An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study

People of Pathology Podcast:

Twitter

Instagram

  continue reading

184 jaksoa

Artwork
iconJaa
 
Manage episode 422792301 series 3385006
Sisällön tarjoaa peopleofpathology. peopleofpathology tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Jospeh Mossel co-founded Ibex in 2016. Since its inception, Ibex has remained committed to developing AI applications for clinical diagnostics.

The company achieved its first milestone in 2018 by deploying its first algorithm for prostate cancer. This algorithm not only enhanced diagnostic efficiency but also detected a diagnostic error, demonstrating the value of AI in pathology.

Over the years, IBEX has expanded its offerings to include algorithms for breast and gastric cancers, facing challenges due to the unique characteristics of each tissue type. However, through partnerships with healthcare organizations and pharmaceutical companies, IBEX has continued to innovate and grow.

This conversation covers the history of Ibex and some of their milestones. We conclude with a look toward the future of AI in pathology.

Links for this episode:

Health Podcast Network

LabVine Learning

Dress A Med scrubs

Digital Pathology Club

Ibex Medical Analytics

An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study

People of Pathology Podcast:

Twitter

Instagram

  continue reading

184 jaksoa

सभी एपिसोड

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas